After years of investment and support from The Jasper L. and Jack Denton Wilson Foundation, Dr. Karl Csaky’s unique patented ocular drug delivery device is approaching human clinical trials. The innovative technology has the potential to reduce or eliminate the need for eye injections.
READ MOREAt the Retina Foundation, research begins with the people it is designed to help. This issue looks at how patient-centered studies and clinical trials are translating scientific discovery into meaningful advances in care, with a continued focus on improving vision and quality of life for patients today.
READ MOREFrom global research partnerships to promising clinical trials, the Retina Foundation is working to move vision science closer to restoring sight. This issue highlights how collaboration, community support, and emerging stem cell research are helping researchers explore new possibilities for patients affected by retinal disease.
READ MOREFrom pediatric discoveries to treatments for age-related vision loss, the Retina Foundation is advancing care for every stage of life. In this issue, we celebrate a research milestone as Dr. Neha Tandon publishes her first peer-reviewed paper in Ophthalmology Science, exploring a new method for measuring central visual function in patients with geographic atrophy, an […]
READ MOREFor five decades, the Retina Foundation of the Southwest has been at the forefront of the fight against blindness. Founded in 1975 in Dallas by Drs. Albert Vaiser, William Snyder, William Hutton, and Joe Turner, Jr., it remains one of only two independent nonprofit eye research institutes in the nation. The mission has never wavered: […]
READ MOREClinical Research Coordinator Eric Vasquez presented findings on retinitis pigmentosa as a National Eye Institute Travel Grant recipient. DALLAS – (June 4, 2026) – The Retina Foundation, a global leader dedicated to preventing vision loss and restoring sight through innovative research and treatment, participated in the annual Association for Research in Vision and Ophthalmology (ARVO) […]
READ MOREThe Retina Foundation hosts its 2026 Visionary Luncheon on Thursday, May 14 at the Morton H. Meyerson Symphony Center, celebrating 50 years of impact and launching the 100 Grand Challenge with a $1.3M fundraising goal. The program features a tribute to Honorary Chair & Co-Founder Dr. William L. Hutton, presentation of the Hunt Family Visionary […]
READ MOREDALLAS – May 6, 2026 – The Retina Foundation, a global medical destination to prevent vision loss and restore sight through innovative research and treatment, will host its signature annual fundraising event, the Visionary Luncheon, on Thursday, May 14 at the Morton H. Meyerson Symphony Center. Dr. Karl Csaky, Chief Strategy Officer for the Retina […]
READ MOREDenver, Colo. (April 21, 2026)—Two studies presented at the Association for Research in Vision and Ophthalmology’s (ARVO) 2026 Annual Meeting explored innovative approaches in advancing treatment options for vision-related neurological conditions. One study identified a potential therapy for amblyopia that may offer benefits beyond traditional approaches. The second study discovered links between inflammation and cholesterol […]
READ MORE
